comparemela.com

Riley Munks News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Reshape Raises $20 Million Series A to Scale AI-Powered Imaging and Analysis Platform for Biotech, Agriculture, and Food R&D

Reshape Raises $20 Million Series A to Scale AI-Powered Imaging and Analysis Platform for Biotech, Agriculture, and Food R&D
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Overmoon Raises $80M, Launches Tax-Deferred Exchange Program for Qualified Vacation Home Owners to Defer Taxes and Enhance Returns

Overmoon, a tech-enabled vacation rental platform, today announced $80M in equity and debt funding from NFX, Khosla Ventures, Camber Creek, 1Sharpe, Sunsar Capital, and others. The funding includes $10M in venture to scale its technology development, $30M in real estate equi

Gizmo Raises $3 5M from NFX to Supercharge Learning with Generative AI Quiz Platform

Gizmo Raises $3 5M from NFX to Supercharge Learning with Generative AI Quiz Platform
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Ramp Expands Global Crypto On-Ramp Service with Additional 40 Currencies

Ramp Expands Global Crypto On-Ramp Service with Additional 40 Currencies
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Gilboa Therapeutics Publishes and Presents Data at AACR Supporting SolidT Engineered T-Cell Platform Targeting Solid Tumors

Gilboa Therapeutics, a preclinical stage biotechnology company, today announced the publication of a scientific paper demonstrating that its novel T-cell therapy platform, SolidT, has the potential to reprogram T cells to detect and destroy solid tumor cells while leaving normal cells unharmed. The paper was published in Cancer Immunology Research, a journal of the American Association for Cancer Research (AACR). The company will be presenting its data in a poster at the AACR Annual Me.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.